Biogen Inc. logo

Biogen Inc. (BIIB)

$229.8

Biogen Inc. (BIIB) Share Price Forecast
Currently 42 wall-street analysts regularly analyze the financials of Biogen Inc. on a frequent basis to provide recommendations along with target share price. 42 analysts offering 12-month price forecasts for Biogen Inc. (BIIB) have a share price target of $283.95. This median of share price forecast represents a 23.56% upside from the latest price of $229.8 as on 04.06.24.

Biogen Inc. (BIIB) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Biogen Inc. (BIIB) share price will touch around $283.95 in next 12-months.
Biogen Inc. (BIIB) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Biogen Inc.'s share price and its median forecast price. As on 04.06.24, the difference is -23.88%

Biogen Inc. (BIIB): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Biogen Inc. (BIIB) Share Price : Analyst Recommendation
Based on 42 analysts tracking and researching Biogen Inc. (BIIB) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
22
20
20
Outperform
10
10
10
Hold
10
12
12
Underperform
0
0
0
Sell
0
0
0
Biogen Inc. (BIIB) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Biogen Inc. (BIIB) is $283.95, offered by 42 analysts offering 12-month price forecasts.

Biogen Inc. (BIIB) has a maximum of 0.24 upside potential, based on 42 analysts offering 12-month price forecasts.

Based on 42 analysts tracking and researching Biogen Inc. (BIIB), 71.43% have a buy recommendation. Remaining 28.57% have either sell or hold recommendations.

The latest share price of Biogen Inc. (BIIB) is $229.8 as of 04/06/2024.

30 of total 42 analysts offering stock ratings for Biogen Inc. BIIB have recommended buy rating.